Article
Maribavir Inhibits Epstein-Barr Virus Transcription in Addition to Viral DNA Replication
17 Sept 2009
Abstract excerpt
Although many drugs inhibit the replication of Epstein-Barr virus (EBV) in cell culture systems, there is still no drug that is effective and approved for use in primary EBV infection. More recently, maribavir (MBV), an l-ribofuranoside benzimidazole, has been shown to be a potent and nontoxic inhibitor of EBV replication and to have a mode of action quite distinct from that of acyclic nucleoside analogs such as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
